MYC and acute myeloid leukemia: In AML cases with dmin, evaluation of other chromosomes and genetic abnormalities associated with poor prognosis is key to predicting prognosis and determining the treatment plan. The impact of dmin and MYC on prognosis in AML is unclear, and careful monitoring after initiation of treatment is necessary.